-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellyan Biotechnology CEO and Director Andy Liang files initial beneficial ownership statement

PUBT·06/08/2026 18:23:50
Listen to the news
Cellyan Biotechnology CEO and Director Andy Liang files initial beneficial ownership statement
  • Cellyan Biotechnology filed a Form 3 naming CEO and director Liang Chenyu Andy as a reporting insider, dated March 18, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-066209), on June 08, 2026, and is solely responsible for the information contained therein.